These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2276987)

  • 1. Growth of Bacteroides fragilis group in agar and broth media.
    Brook I
    J Appl Bacteriol; 1990 Nov; 69(5):697-700. PubMed ID: 2276987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative growth of Bacteroides species in various anaerobic culture media.
    Eley A; Greenwood D; O'Grady F
    J Med Microbiol; 1985 Apr; 19(2):195-201. PubMed ID: 3981610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of viability of Bacteroides fragilis and Bacteroides vulgatus in different media.
    Verweij-van Vught A; Sparrius M; Maclaren D
    Eur J Clin Microbiol; 1985 Aug; 4(4):433-4. PubMed ID: 4043068
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.
    Jacobus NV; Cuchural GJ; Tally FP
    J Antimicrob Chemother; 1989 Nov; 24(5):675-82. PubMed ID: 2599992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective medium for isolation and presumptive identification of the Bacteriodes fragilis group.
    Ushijima T; Takahashi M; Tatewaki K; Ozaki Y
    Microbiol Immunol; 1983; 27(12):985-93. PubMed ID: 6676629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New medium for selection and presumptive identification of the Bacteroides fragilis group.
    Livingston SJ; Kominos SD; Yee RB
    J Clin Microbiol; 1978 May; 7(5):448-53. PubMed ID: 659574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.
    Ho PL; Ho LY; Yau CY; Tong MK; Chow KH
    J Clin Microbiol; 2017 Feb; 55(2):384-390. PubMed ID: 27852672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chilling on the survival of Bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    J Clin Microbiol; 1976 Nov; 4(5):432-6. PubMed ID: 993326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for the production of pre-reduced anaerobically sterilized culture media.
    Gosden PE; Ware GC
    J Appl Bacteriol; 1977 Feb; 42(1):77-9. PubMed ID: 853028
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
    Hecht DW; Lederer L; Osmolski JR
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binary interactions between the yeast Candida albicans and two gut-associated Bacteroides species.
    Valentine M; Benadé E; Mouton M; Khan W; Botha A
    Microb Pathog; 2019 Oct; 135():103619. PubMed ID: 31291601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.
    Namavar F; Theunissen EB; Verweij-Van Vught AM; Peerbooms PG; Bal M; Hoitsma HF; MacLaren DM
    J Med Microbiol; 1989 Jul; 29(3):171-6. PubMed ID: 2746627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish meal extract bile esculin agar (FMBE) a selective medium for Bacteroides fragilis group.
    Beena VK; Rao S; Kotian M; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):361-4. PubMed ID: 9354008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bactericidal action of human serum on Bacteroides species.
    Rotimi VO; Eke PI
    J Med Microbiol; 1984 Dec; 18(3):355-63. PubMed ID: 6502677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance.
    Tierney D; Copsey SD; Morris T; Perry JD
    Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane proteins of Bacteroides fragilis grown in vivo.
    Patrick S; Lutton DA
    FEMS Microbiol Lett; 1990 Sep; 59(1-2):1-4. PubMed ID: 2276600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bacteroides fragilis on blood agar plates and reversal of inhibition by added hemin.
    Wilkins TD; Chalgren SL; Jimenez-Ulate F; Drake CR; Johnson JL
    J Clin Microbiol; 1976 Mar; 3(3):359-63. PubMed ID: 1270596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Bacteroides fragilis keratitis.
    Stern GA; Stock EL
    Arch Ophthalmol; 1978 Dec; 96(12):2264-6. PubMed ID: 718520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bacteroides by-product inhibits human polymorphonuclear leukocyte function.
    Rotstein OD; Pruett TL; Sorenson JJ; Fiegel VD; Nelson RD; Simmons RL
    Arch Surg; 1986 Jan; 121(1):82-8. PubMed ID: 3942502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.